Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Oncotarget. 2016.
Clearance of hematological malignancies by allogeneic cytokine-induced killer cell or donor lymphocyte infusions. Biol Blood Marrow Transplant. 2019.
Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus. Cytotherapy. 2015.
Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells. Pediatr Blood Cancer. 2016.
Depletion of CD45RA T cells: Advantages and disadvantages of different purification methods. J Immunol Methods. 2021:112960.
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. J Clin Oncol. 2018:JCO2018782516.
Human Anti-Aspergillus TH1 cells: Immunosuppressive Compounds Exhibit Particular Effects on Functional Properties. Infect Immun. 2014..
Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients. Transfusion. 2019.
A novel homozygous mutation in UNC13D presenting as Epstein-Barr-virus-associated lymphoproliferative disease at 9 years of age. Leuk Lymphoma. 2016:1-3..
Systemic viral infection in children receiving chemotherapy for acute leukemia. Pediatr Blood Cancer. 2020:e28673..